Zurich Insurance Group’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $44.8M | Buy |
354,330
+13,200
| +4% | +$1.74M | 0.31% | 89 |
|
|
2026
Q1 | $47.5M | Buy |
341,130
+33,365
| +11% | +$4.67M | 0.37% | 72 |
|
|
2025
Q4 | $37.8M | Buy |
307,765
+277,065
| +902% | +$33.7M | 0.26% | 99 |
|
|
2025
Q3 | $3.41M | Sell |
30,700
-255,835
| -89% | -$29.1M | 0.02% | 160 |
|
|
2025
Q2 | $31.8M | Sell |
286,535
-28,889
| -9% | -$3.07M | 0.25% | 91 |
|
|
2025
Q1 | $35.3M | Sell |
315,424
-593,470
| -65% | -$61.2M | 0.29% | 94 |
|
|
2024
Q4 | $84M | Buy |
908,894
+635,209
| +232% | +$57.2M | 0.68% | 37 |
|
|
2024
Q3 | $22.9M | Buy |
273,685
+242,985
| +791% | +$18.5M | 0.19% | 113 |
|
|
2024
Q2 | $2.11M | Hold |
30,700
| – | – | 0.02% | 154 |
|
|
2024
Q1 | $2.25M | Hold |
30,700
| – | – | 0.02% | 162 |
|
|
2023
Q4 | $2.49M | Hold |
30,700
| – | – | 0.03% | 156 |
|
|
2023
Q3 | $2.3M | Buy |
+30,700
| New | +$2.36M | 0.02% | 151 |
|
|
2022
Q3 | – | Sell |
-23,900
| Closed | -$1.48M | – | 241 |
|
|
2022
Q2 | $1.48M | Buy |
+23,900
| New | +$1.48M | 0.02% | 158 |
|
|
2019
Q4 | – | Sell |
-256,609
| Closed | -$16.3M | – | 332 |
|
|
2019
Q3 | $16.3M | Buy |
256,609
+8,579
| +3% | +$561K | 0.31% | 80 |
|
|
2019
Q2 | $16.8M | Buy |
248,030
+41,097
| +20% | +$2.7M | 0.33% | 72 |
|
|
2019
Q1 | $13.5M | Sell |
206,933
-41,127
| -17% | -$2.73M | 0.29% | 101 |
|
|
2018
Q4 | $15.5M | Buy |
248,060
+3,542
| +1% | +$248K | 0.37% | 81 |
|
|
2018
Q3 | $18.9M | Buy |
244,518
+26,871
| +12% | +$2.03M | 0.4% | 67 |
|
|
2018
Q2 | $15.4M | Sell |
217,647
-26,357
| -11% | -$1.86M | 0.35% | 71 |
|
|
2018
Q1 | $18.4M | Buy |
244,004
+56,961
| +30% | +$4.53M | 0.42% | 55 |
|
|
2017
Q4 | $13.4M | Buy |
187,043
+21,488
| +13% | +$1.63M | 0.31% | 70 |
|
|
2017
Q3 | $13.4M | Sell |
165,555
-36,148
| -18% | -$2.76M | 0.37% | 61 |
|
|
2017
Q2 | $14.3M | Buy |
201,703
+14,060
| +7% | +$936K | 0.4% | 53 |
|
|
2017
Q1 | $12.7M | Sell |
187,643
-5,108
| -3% | -$359K | 0.37% | 59 |
|
|
2016
Q4 | $13.8M | Buy |
192,751
+23,807
| +14% | +$1.77M | 0.44% | 48 |
|
|
2016
Q3 | $13.4M | Sell |
168,944
-58,255
| -26% | -$4.73M | 0.45% | 49 |
|
|
2016
Q2 | $19M | Sell |
227,199
-5,727
| -2% | -$508K | 0.66% | 39 |
|
|
2016
Q1 | $21.4M | Sell |
232,926
-11,386
| -5% | -$1.03M | 0.76% | 31 |
|
|
2015
Q4 | $24.7M | Sell |
244,312
-29,509
| -11% | -$3.07M | 0.89% | 28 |
|
|
2015
Q3 | $26.9M | Buy |
+273,821
| New | +$30.4M | 0.99% | 26 |
|
Other funds holding GILD
Zurich Insurance Group's GILD Position: Q2 2026 in Review
Zurich Insurance Group increased its Gilead Sciences (GILD) stake by 3.9% in Q2 2026, buying an estimated $1.74M and bringing the position to 354,330 shares worth $44.8M. The position accounts for 0.31% of the portfolio, ranked #89.
Zurich Insurance Group first reported a position in GILD in Q3 2015 and has held it in 30 quarters since. The position peaked at $84M in Q4 2024. 2,291 funds tracked by Wall St. Rank hold GILD as of Q2 2026.
- Zurich Insurance Group held 354,330 shares of Gilead Sciences worth $44.8M as of Q2 2026.
- Zurich Insurance Group bought 13,200 Gilead Sciences shares in Q2 2026, an estimated $1.74M.
- Gilead Sciences made up 0.31% of Zurich Insurance Group's portfolio in Q2 2026, its #89 holding.
- Zurich Insurance Group first reported a position in Gilead Sciences in Q3 2015 and has held it in 30 quarters since.
- Zurich Insurance Group's Gilead Sciences position peaked at $84M in Q4 2024.
- 2,291 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.
Based on Zurich Insurance Group's 13F filing for Q2 2026, filed 14 Aug 2026.